Zhang Hongtao, Cheng Xin, Richter Mark, Greene Mark I
Pathology and Laboratory Medicine, School of Medicine, University of Pennsylvania, 3620 Hamilton Walk, Philadelphia, Pennsylvania 19104, USA.
Nat Med. 2006 Apr;12(4):473-7. doi: 10.1038/nm1378. Epub 2006 Mar 12.
The ability to detect antigens immunologically is limited by the affinity of the antibodies and the amount of antigens. We have now succeeded in creating a modular, facile amplification system, termed fluorescent amplification catalyzed by T7 polymerase technique (FACTT). Such a system can detect protein targets specifically at subfemtomolar levels ( approximately 0.08 fM). We describe here the detection of Her2 (also known as Neu) from rodent and human sera. FACTT is adaptable to high-throughput screening and automation and provides a practical method to enhance current ELISAs in medical practice.
通过免疫方式检测抗原的能力受到抗体亲和力和抗原量的限制。我们现已成功创建了一种模块化、简便的扩增系统,称为T7聚合酶催化荧光扩增技术(FACTT)。这样的系统能够特异性地检测低至飞摩尔水平(约0.08 fM)的蛋白质靶标。我们在此描述了从啮齿动物和人类血清中检测Her2(也称为Neu)的方法。FACTT适用于高通量筛选和自动化,为在医学实践中增强当前的酶联免疫吸附测定(ELISA)提供了一种实用方法。